Picture ConsulTech GmbH GDPR-compliant E-Col Home Office 650x80px
Document › Details

Biocrates Life Sciences AG. (2/27/13). "Press Release: Biocrates Life Sciences AG to Launch Thermo Edition of Its State-of-the-Art Metabolomics-based Research Kit, AbsoluteIDQ p150". Innsbruck.

Organisations Organisation Biocrates Life Sciences AG
  Group Biocrates (Group)
  Organisation 2 Thermo Fisher (Group)
Products Product AbsoluteIDQ® p150 Kit
  Product 2 TSQ Vantage™ triple-stage quadrupole mass spectrometer
  Index term 2 Thermo Fisher–Biocrates: AbsoluteIDQ Kits, 201302– collab Thermo edition of established AbsoluteIDQ p150 kit for TSQ Vantage Triple Quad MS
Person Person Klocker, Martina (Biocrates 201110 Marketing Manager)

Austrian BIOCRATES Life Sciences AG, prime developer of cutting-edge metabolite metabolomics products, is about to launch the next edition of its well-established research kit, AbsoluteIDQ® p150, for use with Thermo Scientific's TSQ Vantage Triple Stage Quadrupole Mass Spectrometer.

BIOCRATES Life Sciences announces the launch of a new edition of its well-established research kit, AbsoluteIDQ® p150. The kit, which has been available for use with AB Sciex and Waters mass spectrometry systems, has now been designed to also run on Thermo Scientific's TSQ Vantage Triple Stage Quadrupole Mass Spectrometer, enabling even more research labs to harness the power of targeted metabolite quantification based on a ready-to-use kit system. Combined with a robust new ion source, second-generation ion optics and hyperbolic quadrupoles, the Thermo Scientific TSQ Vantage delivers the highest sensitivity with the lowest chemical noise.

AbsoluteIDQ p150 provides extensive metabolic information from a single targeted assay, quantifying 158 metabolites using a FIA-MS/MS method. It features the proprietary MetIDQ™ software, requires minute sample volumes (10 µL), and is suitable for use with a wide range of biological samples, making it an excellent choice for researchers looking for a cost-effective solution to measure endogenous metabolites under quality-controlled conditions in their own lab. The AbsoluteIDQ kits by BIOCRATES have been successfully applied in many different areas, including diabetes, nephrology, sepsis, and CNS disorders, in both clinical and pharmaceutical research.


BIOCRATES Life Sciences AG is a leading biotechnology company focused on the development of metabolomics products as well as in vitro diagnostics (IVDs) for early disease and progression detection in areas such as nephrology, diabetes, oncology, and endocrinology. Our mass spectrometry-based, standardized metabolomic kits and IVDs provide unprecedented accuracy, precision, and multiplexing potential that will help revolutionize the way personalized medicine is applied in R&D and diagnostics.
Please also visit us at

BIOCRATES Life Sciences AG
Martina Klocker
Tel. +43 (0) 512 579823

Record changed: 2016-03-19


Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Biocrates (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group BioPharm America 2020 Digital Event BEU2020 650x81

» top